Full-Time

Operations Manager

Posted on 1/24/2026

Integer Holdings Corporation

Integer Holdings Corporation

1,001-5,000 employees

Medical device CDMO for cardiac devices

No salary listed

Roanoke, VA, USA

In Person

Category
Operations & Logistics (1)
Requirements
  • Accomplished track record in production environments where you owned the responsibilities for delivering results — particularly those KPIs noted above — with at least 3 years of previous leadership experiences
  • First hand experiences implementing and/or sustaining Manufacturing Excellence and Lean practices
  • Demonstrated experiences with strategic and direct management of people in a fast paced and in complex manufacturing environments where products were made to stock and made to order
Responsibilities
  • Be a Strategic Leader
  • Assume responsibility for all production activities associated with a defined product line(s) at one of our manufacturing sites and accept accountability for delivering the Key Performance Goals/Targets established for that product line(s)
  • Serve as a key leader and representative of the Operations’ Team and contribute to the development of the annual goals and objectives for Operations from which your Key Performance Goals/Targets are derived. You may represent the Operations’ Team to the Site Leadership Team.
  • Lead your direct reports which include any combination of Production Supervisors and individual performers within the Operation’s Team
  • Understand and adhere to Integer’s Values and all company policies, procedures, and work instructions defined in your training plan
  • Ensure compliance to the established Quality Management System and all Environmental, Health, Safety, and Security protocols
  • Provide inputs to and lead the execution of the manufacturing-related imperatives reflected in the site Hoshin Plan
  • Develop and execute sustained Continuous Improvement processes
  • Define the goals and objectives for your direct repots with supporting Key Performance Indicators (metrics in Safety, Quality, Delivery, Inventory, and Productivity)
  • Promote talent by developing individual growth and development plans and organizational succession plans
  • Manage by walking around -- going to the Gemba to observe and ask questions and being an active listener
  • Model an open and inclusive communication style at the daily production boards, in the weekly project update meetings, and in the monthly KPI Board reviews and Town Hall meetings
  • Engage with Associates at all levels and across all functions, finding time every week to join them for lunch, during breaks, and inviting them to your diagonal slice meetings
  • Ensure one/one time with your direct reports regularly to monitor performance and check in on progress to Individual Development Plans
  • Interact, as appropriate, directly with your customers, internal and external; support the preparations of customer business reviews and participate in site visits and audits by customers or other parties, as needed
  • Partner with your peers on the Operations’ Team, aligning on strategies, tactics, and actions needed, to achieve Operation’s objectives
  • Collaborate with the R&D and Product Development teams to appropriately prioritize Operations’ resources and support for new product launches
  • Embed Quality within the Operations team – “I own Quality.” Be a standard bearer for Quality in everything we do at Integer, by assuring adherence to our QMS, facilitating corrective and preventive actions, and contributing to the successful attainment of our quality KPI’s and journey to 5 Sigma.
  • Perform other duties, as needed and as directed
  • Champion Manufacturing Excellence:
  • Be a site champion for deployment of the systems and tools to optimize all production activities across the site.
  • Embrace the Manufacturing Excellence culture based on the Integer Production System and its five focus areas:
  • o Strategy Alignment through Site Hoshin Plans, the regular cadence of Sales, Inventory, and Operations’ Planning (SiOP) meetings, and regular updates to the value stream maps.
  • o Leadership of Sustained Change by ensuring production monitoring & improvement activities and deployment of Leader Standard Work.
  • o Standardization through workplace organization & visual controls (5S), Manufacturing Standard Work, and robust training & certification programs.
  • o Associate Engagement promoted through the adoption of standardized problem solving methodologies, behavior-based safety programs, and improvement idea and suggestion systems.
  • o Systems & Process Optimization through adoption of principles of built in quality, optimized scheduling & material system designs, work cell design, and total productive maintenance.
  • Participate in the development and vetting of production plans with representatives from other departments, such as Production, Planning, Continuous Improvement, Customer Service, Quality, and Materials to ensure that production performance standards meet customer requirements
  • Monitor the status of actual daily and longer-term performance against the production plan; drive actions to address off standard performance
  • Achieve above ensuring change management and required customer notification is being followed
Desired Qualifications
  • A master y of problem-solving skills and evidence that you are a critical thinker and thoughtful decision maker
  • Demonstrated financial acumen with the capability to navigate a typical Profit and Loss Statement, explain how the delivered results from this role can affect profitability, and previous experiences managing inventories
  • A tool kit of leadership skills, including awareness of what the concept of Emotional Intelligence is and how you engrain the beliefs that support your strengths as a people-developer
  • A calm demeanor that transcends the high energy, constantly changing production environment
  • A well-developed skill set for planning, executing, and delivering projects on time and on budget
  • A positive, can-do attitude with an underlying belief that failure is not an option
  • While not required for this position, your willingness to consider relocation opportunities and rotational assignments will provide additional opportunities for future career growth and progression within Integer
  • Bachelor’s degree in Operations Management, Engineering, or similar discipline, or even a Master’s degree, in business or a technical discipline
  • U.S. Applicants: EOE/AA Disability/Veteran
Integer Holdings Corporation

Integer Holdings Corporation

View

Integer Holdings Corporation is a large medical device contract development and manufacturing organization (CDMO) that supports medical device makers in cardiac rhythm management, neuromodulation, and cardiovascular markets. It provides end-to-end services from design support to manufacturing, delivering components and finished subsystems such as implants, housings, electrodes, and batteries through its Greatbatch Medical, Lake Region Medical, and Electrochem brands. The company differentiates itself by its scale, breadth of capabilities across multiple medical specialties, established brand portfolio, and global manufacturing footprint that enable reliable, integrated supply. Its goal is to improve patients’ lives worldwide by helping customers bring safe and effective medical technologies to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

1940

Simplify Jobs

Simplify's Take

What believers are saying

  • Board initiated strategic review on April 30, 2026, exploring sale options.
  • Irenic Capital acquired $99M stake in Q4 2025 as top holding.
  • $200M share repurchase authorization signals management confidence in valuation.

What critics are saying

  • Class action lawsuits by Pomerantz and Bleichmar drain cash via settlements by Q4 2026.
  • Three new products cause 3-4% headwind, slashing H2 2026 margins.
  • Irenic activism forces sale at depressed valuation below $93 target in 12 months.

What makes Integer Holdings Corporation unique

  • Integer specializes in contract manufacturing for Cardio & Vascular medical devices.
  • Organic revenue grew 1.3% in Q1 2026 despite flat overall sales.
  • Robust pipeline targets above-market growth by 200 basis points in 2027.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Adoption Assistance

Parental Leave

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Mar 24th, 2026
Integer VP sells $70K in shares as stock drops 28% in a year

Integer Holdings Corporation shares fell 28% following an insider sale disclosure. Tom Thomas, the company's vice president and corporate controller, sold 825 shares of common stock in an open-market transaction on 13 March 2026, according to an SEC Form 4 filing. The transaction was valued at $70,000 at a reported price of $85 per share. The sale represented 15.85% of Thomas's direct holdings at the time. Following the transaction, Thomas holds 4,380 shares worth approximately $364,000. This marks Thomas's third open-market sale since 2018, following previous sales of 884 shares in November and 1,500 shares in April. Integer Holdings manufactures medical devices and components, generating $1.85 billion in trailing twelve-month revenue.

Yahoo Finance
Feb 26th, 2026
Integer Holdings Q4 earnings beat forecasts on strong Cardio & Vascular demand

Integer Holdings, a medical device manufacturer, reported fourth quarter revenue of $472.1 million and adjusted earnings per share of $1.76, both exceeding analyst expectations. The company posted 5% year-on-year revenue growth, driven by strong performance in its Cardio & Vascular segment. CEO Peyman Khales attributed $30 million in operational improvements to higher sales volume, manufacturing efficiencies and expense management. The company guided adjusted earnings per share of $6.54 for 2026, beating analyst estimates by 3.8%. During the earnings call, analysts questioned the narrowing of organic sales guidance, first quarter margin compression and the company's path to above-market growth in 2027. Management emphasised collaborative customer planning and reaffirmed its current strategy despite activist investor involvement.

Intellectia.AI
Feb 23rd, 2026
Irenic Capital takes $99M stake in Integer Holdings as medical device firm posts 8% sales growth

Irenic Capital Management has acquired a $99.11 million stake in Integer Holdings, purchasing 1,263,663 shares in Q4 2026. The position represents 13.7% of Irenic's assets under management, making it the fund's largest disclosed equity holding. Integer Holdings, a medical device company, achieved 8% sales growth in 2025, reaching $1.85 billion in revenue, with adjusted earnings per share rising 21% to $6.40. The company reported fourth-quarter sales of $472 million and net income of $62 million, up 22% year-over-year. Management projects 2026 adjusted earnings per share between $6.29 and $6.78, with plans to achieve organic growth exceeding market rates by 200 basis points in 2027. Benchmark analyst Robert Wasserman upgraded the stock from hold to buy with a $95 price target.

Yahoo Finance
Feb 23rd, 2026
Integer posts 21% adjusted EPS growth but warns of H1 2026 headwinds from slower product adoption

Integer Holdings reported strong 2025 results with sales up 8% and adjusted earnings per share rising 21% to $6.40, alongside margin expansion and $105 million in free cash flow. The company returned capital through a $50 million share repurchase and announced an additional $50 million accelerated share repurchase programme. However, management warned that three newer products representing approximately 6% of 2025 sales are experiencing slower-than-expected adoption, creating a 3%–4% headwind for 2026. The company expects flat-to-slightly-down sales and a 200–250 basis point hit to first-quarter operating margin, with recovery and margin expansion anticipated in the second half. Integer maintained its 2026 midpoint guidance, with year-end net debt expected at $1.17–1.19 billion and net leverage remaining at 3.0 times adjusted EBITDA.

Yahoo Finance
Feb 19th, 2026
Integer faces 2026 headwinds from delayed product launches despite $200M buyback and robust pipeline

Integer Holdings, a medical device contract manufacturing organisation, reported fourth-quarter sales of $472 million, up 5% year-over-year, with adjusted earnings per share at the high end of its October guidance range. For the full year 2025, sales increased 8% on a reported basis and over 6% organically, whilst adjusted operating income rose 13%. The company issued 2026 guidance expecting reported sales to be down 1% to up 1%, with a 3% to 4% headwind from three new products facing lower-than-expected market adoption. However, Integer's underlying business is expected to grow 4% to 6%, in line with the market. Integer repurchased $50 million of shares in Q4 and announced plans for an additional $50 million accelerated share repurchase programme under its $200 million authorisation.

INACTIVE